Fig. S1. Flowchart of subjects and assays. Table S1. Associations between occurrence of A/H3N2 influenza illness and assay titers. Table S2. Increase in proportion of treatment effect on A/H3N2 influenza illness occurrence explained by pairs of assays. Table S3. Estimated titers for 80% protection against A/H3N2 influenza illness. Table S4. Proportions of subjects with titers falling within the 95% confidence interval for 50% protection against A/H3N2 influenza illness. Table S5. Relative vaccine efficacy predicted by the models compared to observed efficacy among subjects in the model A/H3N2 influenza illness.
PDF, 126K